Equilis Prequenza provides active immunisation against equine influenza using the whole influenza virus and Matrix-Ctm adjuvant technology.
Clear opalescent suspension for injection
Per dose of 1 ml:
Equine influenza virus strains:
A/equine-2/ South Africa/4/03 - 50 AU1
A/equine-2/ Newmarket/2/93 - 50 AU1
1 Antigenic Units
Indications for use
Active immunisation of horses from 6 months of age against equine influenza to reduce clinical signs and virus excretion after infection.
Onset of immunity:
2 weeks after completion of the primary vaccination course.
Duration of immunity:
5 months after completion of the primary vaccination course.
12 months after the first revaccination.
Horses - 0 days
Cardboard box with 10 glass vials of 1 ml
Cardboard box with, 5 pre-filled syringes with needles
For full information please refer to the product data sheet. Further information is available on request.
Use Medicines Responsibly. For more information please refer to the Responsible Use sections of the NOAH website.
If you are not the prescribing veterinary surgeon, advice should be sought from the medicine prescriber.
Date of preparation: January 2018